Overview

Vitamin D3 in Systemic Lupus Erythematosus

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the impact of vitamin D3 on the expression of alpha interferon (IFN alpha) expression in systemic lupus erythematosus (SLE) patients with vitamin D deficiency.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator:
Autoimmunity Centers of Excellence
Treatments:
Cholecalciferol
Ergocalciferols
Vitamin D
Vitamins